Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
Cardiovascular related disease is the main cause of death in patients with kidney disease, and “oxidative stress” is thought to be a major contributor by promoting thickening of the heart muscle and stiffening of the arteries. Allopurinol, a drug used safely in the treatment of gout for many years, has been found to dramatically reduce “oxidative stress”. It is therefore hoped that it also reduce…
Related Questions
- Does left ventricular hypertrophy identify the increased risk of coronary heart disease among UK Indian Asians?
- May age onset be relevant in the occurrence of left ventricular hypertrophy in Friedreichs ataxia?
- How reliable is the electrocardiogram in detecting left ventricular hypertrophy in hypertension?
